The impact of cannabis on endurance and performance of athletes - risks and benefits - a literature review
DOI:
https://doi.org/10.12775/JEHS.2024.76.56232Keywords
CBD, THC, cannabinoids, cannabis, physical activity, medical marihuanaAbstract
Introduction and Objective. Cannabis, particularly its active compounds THC (tetrahydrocannabinol) and CBD (cannabidiol), has gained attention in the sports community for its potential therapeutic benefits. Researchers are exploring its use in managing pain, reducing inflammation, enhancing recovery, and alleviating anxiety, making it appealing for treating both acute injuries and chronic conditions in athletes. While CBD is considered safe, THC can impair cognitive functions, potentially affecting performance and increasing the risk of injury. Unlike THC, CBD is not prohibited by the World Anti-Doping Agency (WADA) and is well-tolerated in humans.
Methods. A literature review was conducted using PubMed and Google Scholar, searching terms like "CBD", "THC", "cannabinoids", "physical activity", and "medical marihuana". Articles from the last five years were prioritized.
Brief description of the State of Knowledge. Cannabinoids interact with the body's endocannabinoid system (ECS) and are classified into phytocannabinoids (from cannabis), endocannabinoids (produced by the body), and synthetic cannabinoids (man-made). The two most studied phytocannabinoids are THC, which is psychoactive, and CBD, known for therapeutic benefits like anxiety reduction without intoxication. THC activates both CB1 receptors (in the brain) and CB2 receptors (in immune cells), while CBD modulates these receptors indirectly. Cannabinoids show potential in managing chronic pain, inflammation, and neurological conditions, with some studies suggesting they could replace opioids for pain relief. They may help in injury recovery among athletes.
Conclusions. The consumption of CBD and THC offer both benefits and risks. However, there is insufficient evidence on the direct impact of cannabis use on athletes beyond its role in pain management and recovery. Further research is needed to provide stronger evidence on their effects in sports.
References
Ware MA, Jensen D, Barrette A, Vernec A, Derman W. Cannabis and the Health and Performance of the Elite Athlete. Clin J Sport Med. 2018;28(5):480-484. doi:10.1097/JSM.0000000000000650
Smith PF. Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances. Expert Rev Neurother. 2007;7(9):1157-1163. doi:10.1586/14737175.7.9.1157
Burr JF, Cheung CP, Kasper AM, Gillham SH, Close GL. Cannabis and Athletic Performance. Sports Med. 2021;51(Suppl 1):75-87. doi:10.1007/s40279-021-01505-x
McCartney D, Benson MJ, Desbrow B, Irwin C, Suraev A, McGregor IS. Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research. Sports Med Open. 2020;6(1):27. Published 2020 Jul 6. doi:10.1186/s40798-020-00251-0
Di Marzo V, Melck D, Bisogno T, De Petrocellis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action [published correction appears in Trends Neurosci 1999 Feb;22(2):80]. Trends Neurosci. 1998;21(12):521-528. doi:10.1016/s0166-2236(98)01283-1
Breijyeh Z, Jubeh B, Bufo SA, Karaman R, Scrano L. Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses. Toxins (Basel). 2021;13(2):117. Published 2021 Feb 5. doi:10.3390/toxins13020117
Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014;144:12-41. doi:10.1016/j.drugalcdep.2014.08.005
Blebea NM, Pricopie AI, Vlad RA, Hancu G. Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use. Int J Mol Sci. 2024;25(8):4204. Published 2024 Apr 10. doi:10.3390/ijms25084204
Pintori N, Caria F, De Luca MA, Miliano C. THC and CBD: Villain versus Hero? Insights into Adolescent Exposure. Int J Mol Sci. 2023;24(6):5251. Published 2023 Mar 9. doi:10.3390/ijms24065251
Grotenhermen F, Russo E, Zuardi AW. Even High Doses of Oral Cannabidol Do Not Cause THC-Like Effects in Humans: Comment on Merrick et al. Cannabis and Cannabinoid Research 2016;1(1):102-112; DOI: 10.1089/can.2015.0004. Cannabis Cannabinoid Res. 2017;2(1):1-4. Published 2017 Jan 1. doi:10.1089/can.2016.0036
Hudson R, Renard J, Norris C, Rushlow WJ, Laviolette SR. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation. J Neurosci. 2019;39(44):8762-8777. doi:10.1523/JNEUROSCI.0708-19.2019
Iffland K, Grotenhermen F. An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. Cannabis Cannabinoid Res. 2017;2(1):139-154. Published 2017 Jun 1. doi:10.1089/can.2016.0034
Ng T, Keshock MC. Tetrahydrocannabinol (THC). In: StatPearls. Treasure Island (FL): StatPearls Publishing; November 12, 2023.
Bedillion MF, Claus ED, Wemm SE, Fox HC, Ansell EB. The effects of simultaneous alcohol and cannabis use on subjective drug effects: A narrative review across methodologies. Alcohol Clin Exp Res (Hoboken). 2024;48(6):988-999. doi:10.1111/acer.15322
Oberbarnscheidt T, Miller NS. The Impact of Cannabidiol on Psychiatric and Medical Conditions. J Clin Med Res. 2020;12(7):393-403. doi:10.14740/jocmr4159
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington (DC): National Academies Press (US); January 12, 2017.
Fisar Z. Phytocannabinoids and endocannabinoids. Curr Drug Abuse Rev. 2009;2(1):51-75. doi:10.2174/1874473710902010051
Sharkey KA, Wiley JW. The Role of the Endocannabinoid System in the Brain-Gut Axis. Gastroenterology. 2016;151(2):252-266. doi:10.1053/j.gastro.2016.04.015
Lu HC, Mackie K. Review of the Endocannabinoid System. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6(6):607-615. doi:10.1016/j.bpsc.2020.07.016
Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199-215. doi:10.1038/sj.bjp.0707442
Laprairie RB, Bagher AM, Kelly ME, Denovan-Wright EM. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol. 2015;172(20):4790-4805. doi:10.1111/bph.13250
Bonz A, Laser M, Küllmer S, et al. Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle. J Cardiovasc Pharmacol. 2003;41(4):657-664. doi:10.1097/00005344-200304000-00020
Urits I, Charipova K, Gress K, et al. Adverse Effects of Recreational and Medical Cannabis. Psychopharmacol Bull. 2021;51(1):94-109.
Abeles M, Popofsky S, Wen A, et al. Vaping-associated lung injury caused by inhalation of cannabis oil. Pediatr Pulmonol. 2020;55(1):226-228. doi:10.1002/ppul.24579
Borowska M, Czarnywojtek A, Sawicka-Gutaj N, et al. The effects of cannabinoids on the endocrine system. Endokrynol Pol. 2018;69(6):705-719. doi:10.5603/EP.a2018.0072
Maggirwar SB, Khalsa JH. The Link between Cannabis Use, Immune System, and Viral Infections. Viruses. 2021;13(6):1099. Published 2021 Jun 9. doi:10.3390/v13061099
Johal H, Vannabouathong C, Chang Y, Zhu M, Bhandari M. Medical cannabis for orthopaedic patients with chronic musculoskeletal pain: does evidence support its use?. Ther Adv Musculoskelet Dis. 2020;12:1759720X20937968. Published 2020 Jul 2. doi:10.1177/1759720X20937968
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington (DC): National Academies Press (US); January 12, 2017.
Cohen L, Neuman MG. Cannabis and the Gastrointestinal Tract. J Pharm Pharm Sci. 2020;23:301-313. doi:10.18433/jpps31242
Pandey S, Kashif S, Youssef M, et al. Endocannabinoid system in irritable bowel syndrome and cannabis as a therapy. Complement Ther Med. 2020;48:102242. doi:10.1016/j.ctim.2019.102242
Urits I, Gress K, Charipova K, et al. Cannabis Use and its Association with Psychological Disorders. Psychopharmacol Bull. 2020;50(2):56-67.
Karlsgodt KH. Cannabis Use in Adolescence: Vulnerability to Cognitive and Psychological Effects. Biol Psychiatry Glob Open Sci. 2023;3(2):167-168. Published 2023 Apr 14. doi:10.1016/j.bpsgos.2022.09.004
Peyravian N, Deo S, Daunert S, Jimenez JJ. The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne. J Inflamm Res. 2022;15:2795-2801. Published 2022 May 3. doi:10.2147/JIR.S355489
Baswan SM, Klosner AE, Glynn K, et al. Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders. Clin Cosmet Investig Dermatol. 2020;13:927-942. Published 2020 Dec 8. doi:10.2147/CCID.S286411
Wallace M, Schulteis G, Atkinson JH, et al. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. Anesthesiology. 2007;107(5):785-796. doi:10.1097/01.anes.0000286986.92475.b7
Kraft B, Frickey NA, Kaufmann RM, et al. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers. Anesthesiology. 2008;109(1):101-110. doi:10.1097/ALN.0b013e31817881e1
Raffaeli W, Tenti M, Corraro A, et al. Chronic Pain: What Does It Mean? A Review on the Use of the Term Chronic Pain in Clinical Practice. J Pain Res. 2021;14:827-835. Published 2021 Mar 29. doi:10.2147/JPR.S303186
Hameed M, Prasad S, Jain E, et al. Medical Cannabis for Chronic Nonmalignant Pain Management. Curr Pain Headache Rep. 2023;27(4):57-63. doi:10.1007/s11916-023-01101-w
Busse JW, Wang L, Kamaleldin M, et al. Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis. JAMA. 2018;320(23):2448-2460. doi:10.1001/jama.2018.18472
Nielsen S, Sabioni P, Trigo JM, et al. Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis. Neuropsychopharmacology. 2017;42(9):1752-1765. doi:10.1038/npp.2017.51
Boehnke KF, Litinas E, Clauw DJ. Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. J Pain. 2016;17(6):739-744. doi:10.1016/j.jpain.2016.03.002
Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis [published correction appears in JAMA. 2015 Aug 4;314(5):520. doi: 10.1001/jama.2015.8253] [published correction appears in JAMA. 2015 Aug 25;314(8):837. doi: 10.1001/jama.2015.9010] [published correction appears in JAMA. 2015 Dec 1;314(21):2308. doi: 10.1001/jama.2015.15929] [published correction appears in JAMA. 2016 Apr 12;315(14):1522. doi: 10.1001/jama.2016.3470]. JAMA. 2015;313(24):2456-2473. doi:10.1001/jama.2015.6358
Malek N, Starowicz K. Joint problems arising from lack of repair mechanisms: can cannabinoids help?. Br J Pharmacol. 2019;176(10):1412-1420. doi:10.1111/bph.14204
Amoako AO, Pujalte GG. Osteoarthritis in young, active, and athletic individuals. Clin Med Insights Arthritis Musculoskelet Disord. 2014;7:27-32. Published 2014 May 22. doi:10.4137/CMAMD.S14386
Dubois C, Danielson EC, Beestrum M, Eurich DT. Medical cannabis and its efficacy/effectiveness on the management of osteoarthritis pain and function. Curr Med Res Opin. 2024;40(7):1195-1202. doi:10.1080/03007995.2024.2363945
Braun-Trocchio R, Graybeal AJ, Kreutzer A, et al. Recovery Strategies in Endurance Athletes. J Funct Morphol Kinesiol. 2022;7(1):22. Published 2022 Feb 13. doi:10.3390/jfmk7010022
Pinzone AG, Erb EK, Humm SM, Kearney SG, Kingsley JD. Cannabis use for exercise recovery in trained individuals: a survey study. J Cannabis Res. 2023;5(1):32. Published 2023 Aug 5. doi:10.1186/s42238-023-00198-5
Charest J, Grandner MA. Sleep and Athletic Performance: Impacts on Physical Performance, Mental Performance, Injury Risk and Recovery, and Mental Health. Sleep Med Clin. 2020;15(1):41-57. doi:10.1016/j.jsmc.2019.11.005
Fullagar HH, Skorski S, Duffield R, Hammes D, Coutts AJ, Meyer T. Sleep and athletic performance: the effects of sleep loss on exercise performance, and physiological and cognitive responses to exercise. Sports Med. 2015;45(2):161-186. doi:10.1007/s40279-014-0260-0
Babson KA, Sottile J, Morabito D. Cannabis, Cannabinoids, and Sleep: a Review of the Literature. Curr Psychiatry Rep. 2017;19(4):23. doi:10.1007/s11920-017-0775-9
Ware MA, Jensen D, Barrette A, Vernec A, Derman W. Cannabis and the Health and Performance of the Elite Athlete. Clin J Sport Med. 2018;28(5):480-484. doi:10.1097/JSM.0000000000000650
Cerqueira É, Marinho DA, Neiva HP, Lourenço O. Inflammatory Effects of High and Moderate Intensity Exercise-A Systematic Review. Front Physiol. 2020;10:1550. Published 2020 Jan 9. doi:10.3389/fphys.2019.01550
Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 2009;1(7):1333-1349. doi:10.4155/fmc.09.93
Puffenbarger RA, Boothe AC, Cabral GA. Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia. 2000;29(1):58-69.
Fuster JJ, Walsh K. The good, the bad, and the ugly of interleukin-6 signaling. EMBO J. 2014;33(13):1425-1427. doi:10.15252/embj.201488856
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Paweł Nojek, Gustaw Błaszczyński, Agnieszka Nowotarska, Wiktoria Pawlik, Mariusz Zimonczyk, Monika Zawół
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 795
Number of citations: 0
